+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Human Growth Hormone Market, by Application, by Distribution Channel, by Country, Industry Analysis and Forecast, 2019 - 2025

  • PDF Icon

    Report

  • 94 Pages
  • February 2020
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5006156
The Europe Human Growth Hormone Market is expected to witness market growth of 7.9% CAGR during the forecast period (2019-2025).

In addition, initiatives taken by various government and private organizations to raise awareness of GH deficiencies and human growth hormone therapy are expected to drive the market. Every year, the International Coalition of Organizations Supporting Endocrine Patients (ICOSEP), celebrates International Children's Growth Awareness Day to raise awareness about early diagnosing and treating growth hormone disorders among humans, particularly children. Nevertheless, the high cost of HGH treatment and the multiple adverse effects associated with HGH could impede market growth over the forecast period. For example, as per UPMC Children's Hospital in Pittsburgh, potential side effects of GH hormone therapy are hip, knee, or other joint pain; allergic reactions, including rash, swelling, or hives; and increased blood sugar levels.

The human growth hormone is very common among bodybuilders and athletes due to the many benefits it offers. Besides burning fat, it is also very effective for muscle building. Because of a possible muscle growth and strength benefit, bodybuilders and athletes who have been tempted to take performance-enhancing drugs and supplements such as steroids have taken HGH to achieve an athletic advantage, or for rapid, aesthetic muscle growth. Because digestion can break down HGH taken orally, it is injected when it is used as a supplementary drug. The bodybuilding industry was the first to find that HGH wasn't just some drug to help growing children. This industry was also the first to quickly understand HGH's anabolic properties and it could help them in achieving their only goal of a huge, youthful, well-ripped body.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.

Scope of the Study

Market Segmentation:

By Application
  • Small for Gestational Age
  • Prader-Willi Syndrome
  • Idiopathic Short Stature
  • Turner Syndrome
  • Growth Hormone Deficiency and
  • Pediatric Growth Hormone Deficiency
  • Adult Growth Hormone Deficiency
  • Other Applications

By Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Pharmacy
  • Online Pharmacy

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • Merck Group
  • Teva Pharmaceuticals Industries Ltd.
  • Ipsen Pharma Biotech SAS
  • Novartis AG (Sandoz International GmbH)
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
  • Ferring Holdings SA
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Anhui Anke Biotechnology Group Co., Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Human Growth Hormone Market, by Application
1.4.2 Europe Growth Hormone Deficiency Application Market, by Type
1.4.3 Europe Human Growth Hormone Market, by Distribution Channel
1.4.4 Europe Human Growth Hormone Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Human Growth Hormone Market by Application
3.1 Europe Small for Gestational Age Market by Country
3.2 Europe Prader-Willi Syndrome Market by Country
3.3 Europe Idiopathic Short Stature Market by Country
3.4 Europe Turner Syndrome Market by Country
3.5 Europe Growth Hormone Deficiency Market by Country
3.5.1 Europe Growth Hormone Deficiency Application Market by Type
3.5.1.1 Europe Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 Europe Adult Growth Hormone Deficiency Market by Country
3.6 Europe Other Applications Market by Country
Chapter 4. Europe Human Growth Hormone Market by Distribution Channel
4.1 Europe Retail Pharmacy Market by Country
4.2 Europe Hospital Pharmacy Market by Country
4.3 Europe Specialty Pharmacy Market by Country
4.4 Europe Online Pharmacy Market by Country
Chapter 5. Europe Human Growth Hormone Market by Country
5.1 Germany Human Growth Hormone Market
5.1.1 Germany Human Growth Hormone Market by Application
5.1.1.1 Germany Growth Hormone Deficiency Application Market by Type
5.1.2 Germany Human Growth Hormone Market by Distribution Channel
5.2 UK Human Growth Hormone Market
5.2.1 UK Human Growth Hormone Market by Application
5.2.1.1 UK Growth Hormone Deficiency Application Market by Type
5.2.2 UK Human Growth Hormone Market by Distribution Channel
5.3 France Human Growth Hormone Market
5.3.1 France Human Growth Hormone Market by Application
5.3.1.1 France Growth Hormone Deficiency Application Market by Type
5.3.2 France Human Growth Hormone Market by Distribution Channel
5.4 Russia Human Growth Hormone Market
5.4.1 Russia Human Growth Hormone Market by Application
5.4.1.1 Russia Growth Hormone Deficiency Application Market by Type
5.4.2 Russia Human Growth Hormone Market by Distribution Channel
5.5 Spain Human Growth Hormone Market
5.5.1 Spain Human Growth Hormone Market by Application
5.5.1.1 Spain Growth Hormone Deficiency Application Market by Type
5.5.2 Spain Human Growth Hormone Market by Distribution Channel
5.6 Italy Human Growth Hormone Market
5.6.1 Italy Human Growth Hormone Market by Application
5.6.1.1 Italy Growth Hormone Deficiency Application Market by Type
5.6.2 Italy Human Growth Hormone Market by Distribution Channel
5.7 Rest of Europe Human Growth Hormone Market
5.7.1 Rest of Europe Human Growth Hormone Market by Application
5.7.1.1 Rest of Europe Growth Hormone Deficiency Application Market by Type
5.7.2 Rest of Europe Human Growth Hormone Market by Distribution Channel
Chapter 6. Company Profiles
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview

Companies Mentioned

  • Merck Group
  • Teva Pharmaceuticals Industries Ltd.
  • Ipsen Pharma Biotech SAS
  • Novartis AG (Sandoz International GmbH)
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
  • Ferring Holdings SA
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Anhui Anke Biotechnology Group Co., Ltd.

Methodology

Loading
LOADING...